Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 22  •  02:38PM ET
2.47
Dollar change
-0.20
Percentage change
-7.49
%
Index- P/E- EPS (ttm)-0.57 Insider Own0.32% Shs Outstand67.16M Perf Week-15.41%
Market Cap165.88M Forward P/E24.70 EPS next Y0.10 Insider Trans0.00% Shs Float66.94M Perf Month-29.02%
Enterprise Value133.30M PEG- EPS next Q-0.06 Inst Own9.49% Short Float6.78% Perf Quarter-9.85%
Income-12.71M P/S- EPS this Y67.12% Inst Trans100.00% Short Ratio1.05 Perf Half Y18.75%
Sales0.00M P/B3.09 EPS next Y141.67% ROA-62.65% Short Interest4.54M Perf YTD120.54%
Book/sh0.80 P/C5.07 EPS next 5Y- ROE-69.80% 52W High4.67 -47.11% Perf Year152.04%
Cash/sh0.49 P/FCF- EPS past 3/5Y22.83% 15.51% ROIC-41.80% 52W Low0.89 177.53% Perf 3Y-47.78%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility6.59% 6.82% Perf 5Y-69.05%
Dividend TTM- EV/Sales- EPS Y/Y TTM29.39% Oper. Margin- ATR (14)0.24 Perf 10Y-99.63%
Dividend Ex-Date- Quick Ratio12.06 Sales Y/Y TTM- Profit Margin- RSI (14)32.39 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio12.06 EPS Q/Q42.23% SMA20-18.13% Beta1.25 Target Price12.00
Payout- Debt/Eq0.00 Sales Q/Q- SMA50-26.09% Rel Volume1.04 Prev Close2.67
Employees21 LT Debt/Eq0.00 EarningsAug 12 SMA200-0.87% Avg Volume4.32M Price2.47
IPOMar 25, 1992 Option/ShortYes / Yes EPS/Sales Surpr.-25.00% - Trades Volume3,609,081 Change-7.49%
Date Action Analyst Rating Change Price Target Change
Jan-13-20Reiterated H.C. Wainwright Buy $12 → $26
Dec-24-19Reiterated H.C. Wainwright Buy $10 → $12
Jan-31-18Initiated Ladenburg Thalmann Buy $1.75
Oct-20-25 09:20AM
Oct-16-25 08:30AM
Oct-14-25 08:30AM
Oct-07-25 08:00AM
Oct-01-25 09:00AM
12:00PM Loading…
Sep-26-25 12:00PM
Sep-23-25 08:30AM
Sep-19-25 10:26AM
Sep-16-25 03:37PM
Sep-15-25 08:00AM
Sep-09-25 01:25PM
08:28AM
01:30AM
Sep-08-25 08:28AM
Aug-25-25 10:30AM
01:33PM Loading…
Aug-21-25 01:33PM
Aug-20-25 08:30AM
Aug-08-25 08:00AM
Aug-06-25 06:46AM
Aug-05-25 08:30AM
Jul-22-25 08:30AM
Jul-09-25 07:20AM
Jul-08-25 08:30AM
Jun-30-25 08:30AM
Jun-17-25 08:30AM
Jun-12-25 12:00PM
Jun-09-25 09:05AM
08:30AM
Jun-05-25 08:30AM
Apr-23-25 08:30AM
03:26PM Loading…
Apr-18-25 03:26PM
Apr-15-25 09:00AM
Apr-10-25 09:00AM
Apr-09-25 08:30AM
Apr-01-25 08:30AM
Mar-04-25 08:30AM
Feb-25-25 08:30AM
Feb-11-25 06:15PM
Feb-10-25 08:00AM
Feb-04-25 08:30AM
Feb-03-25 07:07PM
Jan-21-25 08:30AM
Jan-13-25 08:30AM
Jan-10-25 10:25AM
Jan-09-25 08:22AM
Jan-08-25 08:00AM
Jan-07-25 04:15PM
Jan-06-25 08:00AM
Dec-30-24 08:30AM
Dec-11-24 05:00AM
Dec-10-24 10:18AM
08:00AM
Dec-03-24 08:45AM
Oct-15-24 11:21AM
08:38AM
Sep-30-24 08:30AM
Sep-17-24 08:30AM
Aug-29-24 05:32AM
Aug-23-24 11:59AM
Aug-22-24 08:30AM
Aug-19-24 11:01AM
Aug-13-24 08:30AM
Aug-05-24 11:29AM
Aug-02-24 06:52AM
Aug-01-24 08:30AM
Jul-18-24 08:30AM
Jul-11-24 01:47PM
Jul-09-24 08:30AM
Jul-08-24 08:20AM
Jul-05-24 11:48AM
08:13AM
Jul-04-24 01:49PM
Jul-03-24 08:20AM
Jun-26-24 11:14AM
Jun-21-24 06:53AM
Jun-20-24 08:25AM
Jun-17-24 08:30AM
Jun-04-24 04:20PM
06:26AM
Jun-03-24 12:11PM
08:20AM
May-15-24 11:53PM
Apr-29-24 08:30AM
Apr-15-24 08:30AM
Mar-27-24 10:53PM
Feb-07-24 10:08AM
Feb-05-24 07:30AM
Jan-30-24 07:20AM
Jan-18-24 07:20AM
Jan-03-24 10:12AM
Dec-29-23 08:00AM
Dec-28-23 07:30AM
Dec-14-23 08:15AM
Dec-10-23 02:31PM
Dec-07-23 08:00AM
Nov-21-23 09:12AM
Nov-13-23 08:30AM
Nov-08-23 09:10AM
Oct-31-23 08:25AM
Oct-24-23 08:19AM
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.